The Latest Headlines at Watch List News
Typerium Trading Down 20.8% Over Last 7 Days (TYPE)
Typerium (CURRENCY:TYPE) traded 2.6% lower against the dollar during the 1 day period ending at 14:00 PM ET on June 20th. One Typerium coin can now be purchased for approximately $0.0003 or 0.00000001 BTC on major exchanges. During... More of this article »
Refereum (RFR) Trading 7% Lower This Week
Refereum (CURRENCY:RFR) traded 4.4% lower against the U.S. dollar during the twenty-four hour period ending at 14:00 PM ET on June 20th. One Refereum coin can currently be purchased for $0.0068 or 0.00000020 BTC on popular cryptocurrency... More of this article »
DDKoin Market Capitalization Tops $948,485.61 (DDK)
DDKoin (CURRENCY:DDK) traded 4.4% lower against the US dollar during the 24 hour period ending at 14:00 PM ET on June 20th. One DDKoin coin can currently be bought for $0.55 or 0.00001588 BTC on popular exchanges. DDKoin has a total... More of this article »
Zacks: Analysts Expect Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) to Announce -$0.47 EPS
Equities analysts expect Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) to report earnings per share of ($0.47) for the current quarter, Zacks reports. Zero analysts have provided estimates for Cyclacel Pharmaceuticals’ earnings,... More of this article »
Primis Financial Corp. (NASDAQ:FRST) Expected to Post Earnings of $0.26 Per Share
Wall Street brokerages expect that Primis Financial Corp. (NASDAQ:FRST) will post earnings per share (EPS) of $0.26 for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Primis Financial’s... More of this article »
Brokerages Expect American Well Co. (NYSE:AMWL) to Post -$0.19 Earnings Per Share
Equities analysts forecast that American Well Co. (NYSE:AMWL) will announce earnings per share of ($0.19) for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for American Well’s earnings.... More of this article »
$4.30 Million in Sales Expected for Intrusion Inc. (NASDAQ:INTZ) This Quarter
Equities research analysts expect Intrusion Inc. (NASDAQ:INTZ) to post sales of $4.30 million for the current quarter, according to Zacks. Two analysts have issued estimates for Intrusion’s earnings, with estimates ranging from... More of this article »
Nano (NANO) Hits Market Cap of $762.86 Million
Nano (CURRENCY:NANO) traded 1.2% lower against the dollar during the 24 hour period ending at 14:00 PM ET on June 20th. Nano has a market capitalization of $762.86 million and $30.99 million worth of Nano was traded on exchanges in... More of this article »
Vortex Defi Price Down 4.5% This Week (VTX)
Vortex Defi (CURRENCY:VTX) traded down 6.4% against the US dollar during the 1 day period ending at 14:00 PM Eastern on June 20th. Vortex Defi has a total market capitalization of $77,601.76 and approximately $4,077.00 worth of Vortex... More of this article »
Ormeus Cash (OMC) Price Hits $0.0021 on Exchanges
Ormeus Cash (CURRENCY:OMC) traded down 3.4% against the US dollar during the 1 day period ending at 14:00 PM Eastern on June 20th. Ormeus Cash has a total market capitalization of $402,125.56 and approximately $140,729.00 worth of... More of this article »
Razor Network Reaches Market Cap of $5.49 Million (RAZOR)
Razor Network (CURRENCY:RAZOR) traded 10.5% lower against the US dollar during the twenty-four hour period ending at 14:00 PM ET on June 20th. One Razor Network coin can now be purchased for $0.0626 or 0.00000180 BTC on major exchanges.... More of this article »
UpToken (UP) Price Down 12.2% Over Last 7 Days
UpToken (CURRENCY:UP) traded 2.6% lower against the dollar during the 24-hour period ending at 14:00 PM E.T. on June 20th. One UpToken coin can currently be purchased for $0.0015 or 0.00000004 BTC on major exchanges. In the last week,... More of this article »
$460,000.00 in Sales Expected for Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) This Quarter
Brokerages forecast that Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) will report sales of $460,000.00 for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for Infinity Pharmaceuticals’... More of this article »